TranscriptsOct. 14, 2025 6:56 PM ETApyx Medical Corporation (APYX) StockAPYXSA Transcripts155.82K FollowersApyx Medical Corporation - Special CallCompany ParticipantsCharles Goodwin - President, CEO & DirectorConference Call ParticipantsPaul VanekSam Eiber - BTIG, LLC, Research DivisionMatthew Hewitt - Craig-Hallum Capital Group LLC, Research DivisionAlex Fuhrman - Lucid Capital Markets, LLC, Research DivisionDavid Turkaly - Citizens JMP Securities, LLC, Research DivisionJeremy Feffer - Lifesci Advisors, LLCPresentationOperatorGood afternoon, and welcome to the Apyx Medical Virtual KOL event. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Apyx Medical website following the conclusion of the event.I'd now like to turn the call over to your host, Charlie Goodwin, President and CEO of Apyx Medical. Please go ahead, Charlie.Charles GoodwinPresident, CEO & DirectorThanks, Tara, and thank you for everybody who's taking time today to join us on this call. It is my pleasure to have you here, and it is my pleasure to have Dr. Vanek here as our KOL, and I'm sure you'll find what he has to say, very exciting.Next slide, please. All right, next slide. A brief agenda of what we'll do today is, obviously, there's an introduction from me. We'll talk about the commercial launch of AYON. The majority of the time will be spent with Dr. Vanek, and he will be talking about his experience with AYON, and then we'll conclude the meeting and then open the call for Q&A at the end.Next. So at Apyx Medical, we actually view ourselves as the leader in surgical aesthetics. And surgical aesthetics is different from all other forms of aesthetics because in surgery, we actually believe that, that is the only thing that really provides durable and transformational results for patients. And the market is uniquely changed because of the GLP-1 drugs for weight loss.Read more current APYX analysis and newsView all earnings call transcriptsCommentsRecommended For You